NHS rollout of artificial pancreas narrows inequality in diabetes care
Summary
The NHS has introduced an artificial pancreas device for people with type 1 diabetes, helping to reduce gaps in treatment access between different ethnic and economic groups. This device combines a glucose sensor, an insulin pump, and a computer algorithm to better control blood sugar levels and ease diabetes management.Key Facts
- The artificial pancreas is a hybrid closed-loop system with three parts: a continuous glucose monitor, an algorithm, and an insulin pump.
- It reduces the mental effort needed to manage diabetes, especially at mealtimes and overnight.
- Previously, minority ethnic groups and people from poorer backgrounds had less access to diabetes technology like glucose monitors.
- Since the NHS started the artificial pancreas rollout, uptake differences between deprived and less deprived groups and between ethnic groups have dropped to about 3%.
- Around 32,000 children have received the device in the first two years, covering about 72% of those eligible.
- The program will expand to include all children and adults eligible for the device.
- Users report life-changing benefits, such as fewer hospital visits and easier insulin management, even when cultural or personal challenges exist.
- Advocacy groups highlight the UK as a global leader in this technology and emphasize the need for equal access across all UK regions.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.